지원사업
학술연구/단체지원/교육 등 연구자 활동을 지속하도록 DBpia가 지원하고 있어요.
커뮤니티
연구자들이 자신의 연구와 전문성을 널리 알리고, 새로운 협력의 기회를 만들 수 있는 네트워킹 공간이에요.
논문 기본 정보
- 자료유형
- 학술저널
- 저자정보
- 발행연도
- 2023.1
- 수록면
- 138 - 148 (11page)
- DOI
- 10.23876/j.krcp.21.159
이용수
초록· 키워드
오류제보하기
Background: Generally, an induction agent is chosen based on the conditions of the deceased donor and the recipient. Antithymocyte globulin (ATG) is preferred in relatively high-risk conditions. No clear evidence indicates which induction agent is safer or more efficient for deceased donor kidney transplantation (DDKT). This study compares the efficacy and safety of basiliximab (BSX) and ATG according to donor characteristics in DDKT. Methods: A total of 724 kidney transplant recipients from three transplant centers were enrolled, and propensity score matching was performed. Based on a donor age of 60 years, donor kidney with acute kidney injury (AKI), and Kidney Donor Profile Index (KDPI) score of 65%, we investigated how the choice of induction therapy agent affected the posttransplant clinical outcomes of delayed graft function (DGF), acute rejection (AR), infectious complications, and allograft and patient survival. Results: AR and DGF did not differ significantly according to induction agent in elderly/young donor, AKI/non-AKI, and high-KDPI/low-KDPI subgroups. The infection rate did not show meaningful differences. The differences in death-censored allograft survival and patient survival rates between induction agents were not statistically significant.Conclusion: Our study suggests that BSX can produce clinical outcomes similarly favorable to those of ATG even in DDKT cases with relatively poor donor conditions. Nonetheless, the donor and recipient conditions, immunological risk, and infection risk must be all taken into consideration when choosing an induction agent. Therefore, clinicians should carefully select the induction therapy agent for DDKT based on the risks and benefits in each DDKT case.
목차
등록된 정보가 없습니다.
참고문헌 (0)
참고문헌 신청함께 읽어보면 좋을 논문
논문 유사도에 따라 DBpia 가 추천하는 논문입니다. 함께 보면 좋을 연관 논문을 확인해보세요!
-
Impact of acute kidney injury in deceased donors with high Kidney Donor Profile Index on posttransplant clinical outcomes: a multicenter cohort study
Kidney Research and Clinical Practice
2021 .01
-
Comparison of the Clinical Outcomes between Anti-thymocyte Globulin and Basiliximab Induction Therapy in Deceased Donor Kidney Transplantation: Single Center Experience
Clinical Transplantation and Research
2015 .01
-
Kidney transplantation using expanded criteria deceased donors with terminal acute kidney injury : a single center experience in Korea
Annals of Surgical Treatment and Research
2018 .11
-
Recipient efficacy and safety of kidney transplantation from older living donor: consideration for using older kidney as a solution to the shortage of organs
Clinical Transplantation and Research
2021 .12
-
생체신장이식 수혜자 및 공여자 평가
대한내과학회지
2020 .08
-
The Need for New Donor Stratification to Predict Graft Survival in Deceased Donor Kidney Transplantation
Yonsei Medical Journal
2017 .01
-
Factors of Acute Kidney Injury Donors Affecting Outcomes of Kidney Transplantation from Deceased Donors
대한외과학회 학술대회 초록집
2019 .05
-
Impact of preoperative ultrasonography for predicting the prognosis of deceased donor kidney transplantation
ULTRASONOGRAPHY
2023 .04
-
Comparison of clinical outcomes of deceased donor kidney transplantations, with a focus on three induction therapies
Clinical Transplantation and Research
2019 .01
-
Living donor liver transplantation using donors older than 50 years of age: Recipient criteria and donor risk
Annals of Hepato-Biliary-Pancreatic Surgery
2022 .12
-
Outcomes of deceased donor liver transplantation from elderly donors
Clinical Transplantation and Research
2021 .01
-
Outcomes of deceased donor liver transplantation from elderly donors
Annals of Hepato-Biliary-Pancreatic Surgery
2021 .12
-
Comparison of outcome between low dose rabbit Antithymocyte Globulin and Basiliximab in Low -risk Living Donor Kidney transplantation
대한외과학회 학술대회 초록집
2019 .10
-
Kidney Transplantation From Deceased Donors With Bloodstream Infection: A Multicenter Retrospective Study
Journal of Korean Medical Science
2022 .01
-
The Korean Organ Transplantation Registry (KOTRY): an overview and summary of the kidney-transplant cohort
Kidney Research and Clinical Practice
2022 .07
-
뇌사자신장이식에서 KONOS의 경계공여자 기준의 개선을 위한 다기관 연구 수행의 타당성을 평가하기 위한 예비연구
Clinical Transplantation and Research
2017 .01
-
[Vascular Surgery/ Transplantation] Cysteine as a Potential Donor Urinary Biomarker for Donor Acute Kidney Injury and Recipient Early Graft Function
대한외과학회 학술대회 초록집
2022 .05
-
Metabolic risks in living kidney donors in South Korea
Kidney Research and Clinical Practice
2021 .12
-
Antithymocyte globulin versus basiliximab induction for kidney transplantation in elderly patients: matched analysis within the Korean multicentric registry
Kidney Research and Clinical Practice
2022 .09
-
Impact of extended living donor criteria focusing on donor safety in living donor liver transplantation
Annals of Hepato-Biliary-Pancreatic Surgery
2021 .12
이 논문의 저자 정보
최근 본 자료
댓글(0)
0